Literature DB >> 15090844

Pitfalls in diagnostic immunohistology.

Anthony S-Y Leong1.   

Abstract

The integration of immunostaining as an often-essential component of morphologic assessment makes it necessary that pathologists are familiar with the many technical and interpretive pitfalls that may arise because of the wide variety of factors that can significantly influence the ability to demonstrate relevant antigens in paraffin-embedded tissue sections. Pre-analytical variables that affect immunostaining include fixation, type of fixative, duration, temperature, and pH of fixation, variables in tissue processing, antigen loss resulting from delays in fixation, tissue necrosis, and levels of antigen expression. Analytical factors relate to the complex and sometimes capricious immunolabeling procedure that has as variables the specificity and sensitivity of the antibody clone, reagent dilution, detection system, and chromogen, and importantly, the method of antigen retrieval, which has its own set of variables such as time, temperature, method of heat generation, retrieval solution pH and molarity, and the synergistic action of proteolytic digestion. To obtain the highest diagnostic yield from immunostaining the correct questions must be asked and the pathologist must have familiarity with the characteristics of the antibody, its cross reactivity, if any, and localization of antigen in the cell to understand thresholds and cut-off levels and to recognize false-positive staining. Proper utilization of immunostaining requires that it is employed as a morphology-based technique and not interpreted in isolation.

Entities:  

Mesh:

Year:  2004        PMID: 15090844     DOI: 10.1097/00125480-200403000-00002

Source DB:  PubMed          Journal:  Adv Anat Pathol        ISSN: 1072-4109            Impact factor:   3.875


  16 in total

1.  Immunolabeling artifacts and the need for live-cell imaging.

Authors:  Ulrike Schnell; Freark Dijk; Klaas A Sjollema; Ben N G Giepmans
Journal:  Nat Methods       Date:  2012-01-30       Impact factor: 28.547

2.  Antigen retrieval with protease digestion applied in immunohistochemical diagnosis of Alport syndrome.

Authors:  Na Guan; Li-Xia Yu; Guo-Hong Wu; Yan Xing; Jie Ding
Journal:  Nephrol Dial Transplant       Date:  2008-06-03       Impact factor: 5.992

3.  Immunohistochemistry in the evaluation of neovascularization in tumor xenografts.

Authors:  D Wang; C R Stockard; L Harkins; P Lott; C Salih; K Yuan; D Buchsbaum; A Hashim; M Zayzafoon; R W Hardy; O Hameed; W Grizzle; G P Siegal
Journal:  Biotech Histochem       Date:  2008-06       Impact factor: 1.718

Review 4.  The changing role of pathology in breast cancer diagnosis and treatment.

Authors:  Anthony S-Y Leong; Zhengping Zhuang
Journal:  Pathobiology       Date:  2011-06-14       Impact factor: 4.342

5.  Tissue microarrays as a tool in the discovery and validation of predictive biomarkers.

Authors:  Stephen M Hewitt
Journal:  Methods Mol Biol       Date:  2012

Review 6.  Newer developments in immunohistology.

Authors:  A S-Y Leong; T Y-M Leong
Journal:  J Clin Pathol       Date:  2006-11       Impact factor: 3.411

7.  Growth differentiation factor 15: a prognostic marker for recurrence in colorectal cancer.

Authors:  U Wallin; B Glimelius; K Jirström; S Darmanis; R Y Nong; F Pontén; C Johansson; L Påhlman; H Birgisson
Journal:  Br J Cancer       Date:  2011-04-05       Impact factor: 7.640

8.  Visualization and quantitation of the expression of microRNAs and their target genes in neuroblastoma single cells using imaging cytometry.

Authors:  Eugene D Ponomarev; Tatiana Veremeyko; Natasha S Barteneva
Journal:  BMC Res Notes       Date:  2011-11-28

9.  The effect of erythropoietin on normal and neoplastic cells.

Authors:  Steve Elliott; Angus M Sinclair
Journal:  Biologics       Date:  2012-06-27

Review 10.  Revisiting the technical validation of tumour biomarker assays: how to open a Pandora's box.

Authors:  Caterina Marchiò; Mitch Dowsett; Jorge S Reis-Filho
Journal:  BMC Med       Date:  2011-04-19       Impact factor: 8.775

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.